| Not Yet Recruiting | A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Ot Colo-rectal Cancer | Phase 2 | 2025-08-01 |
| Withdrawn | A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Colon Cancer | Phase 2 | 2022-06-24 |
| Unknown | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patien Metastatic Colorectal Cancer | Phase 1 | 2019-05-15 |
| Completed | Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treat Breast Cancer | Phase 2 | 2018-10-22 |
| Unknown | Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Meta Metastatic Colorectal Cancer | Phase 2 | 2018-05-18 |
| Unknown | Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With HER2-negative Breast Cancer | Phase 2 | 2018-05-14 |
| Completed | Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer Rectal Cancer | Phase 2 | 2018-05-14 |
| Active Not Recruiting | Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breas Triple Negative Breast Cancer | Phase 3 | 2017-12-19 |
| Completed | Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Pr Colorectal Cancer Metastatic | Phase 2 | 2017-07-31 |
| Terminated | A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer Stage III (IIIB or IIIC) Colon Cancer | Phase 3 | 2016-06-01 |
| Completed | A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib W Breast Cancer, Breast Carcinoma, Breast Tumors | Phase 2 | 2015-01-01 |
| Withdrawn | Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer Colorectal Cancer, Metastatic Colorectal Cancer | Phase 2 | 2014-11-01 |
| Completed | A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women Wi Breast Cancer | Phase 1 / Phase 2 | 2014-08-01 |
| Withdrawn | Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Col Colorectal Cancer | Phase 1 / Phase 2 | 2013-10-01 |
| Active Not Recruiting | Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Tre Stage IB Breast Cancer, Stage II Breast Cancer | N/A | 2013-08-01 |
| Unknown | NSABP Biospecimen Discovery Project Breast Cancer | — | 2013-07-01 |
| Completed | NSABP Patient Registry and Biospecimen Profiling Repository Colorectal Cancer | — | 2013-02-01 |
| Completed | Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locall Breast Cancer, HER2-negative Breast Cancer | Phase 2 | 2012-09-01 |
| Unknown | Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negati Breast Cancer | Phase 3 | 2012-04-01 |
| Unknown | Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Can Breast Cancer | — | 2011-11-01 |
| Unknown | Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on N Breast Cancer | — | 2011-10-01 |
| Completed | Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Can Breast Cancer | — | 2011-08-01 |
| Unknown | Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin Breast Cancer, Depression, Fatigue | — | 2011-07-01 |
| Completed | Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Breast Cancer | Phase 1 | 2011-05-01 |
| Completed | Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postope Breast Cancer | Phase 2 | 2010-10-01 |
| Terminated | Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metast Colorectal Cancer, Metastatic Cancer | Phase 3 | 2010-08-01 |
| Terminated | Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Colorectal Cancer, Precancerous Condition | Phase 3 | 2010-03-01 |
| Completed | A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Co Metastatic Colorectal Cancer | Phase 2 | 2010-01-01 |
| Completed | A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-P Breast Cancer | Phase 3 | 2009-05-01 |
| Unknown | Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Breast Cancer | — | 2009-04-01 |
| Terminated | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus T Breast Cancer | Phase 3 | 2008-04-01 |
| Unknown | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surge Invasive Breast Cancer | Phase 3 | 2007-07-01 |
| Completed | Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BE Breast Cancer | Phase 2 | 2007-05-01 |
| Completed | Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Breast Cancer | N/A | 2007-01-01 |
| Completed | Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults | — | 2006-11-01 |
| Unknown | Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer Breast Cancer | Phase 3 | 2006-11-01 |
| Completed | Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Breast Cancer | Phase 2 | 2006-08-01 |
| Unknown | Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Bre Breast Cancer | Phase 3 | 2006-08-01 |
| Withdrawn | Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radi Rectal Cancer, Neoplasm Metastasis | Phase 2 | 2006-06-01 |
| Completed | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Remove Colorectal Cancer | Phase 2 | 2006-03-01 |
| Terminated | Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatm Colorectal Neoplasms | Phase 2 | 2006-03-01 |
| Terminated | Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patient Colorectal Cancer, Metastatic Cancer | Phase 3 | 2006-01-01 |
| Completed | Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer Breast Neoplasms | Phase 2 | 2005-04-01 |
| Completed | Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ o Breast Cancer | N/A | 2005-03-01 |
| Completed | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Breast Cancer | Phase 3 | 2004-10-01 |
| Unknown | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treati Colorectal Cancer | Phase 3 | 2004-07-01 |
| Terminated | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer Colorectal Cancer | Phase 3 | 2004-07-01 |
| Completed | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer Breast Cancer | Phase 3 | 2004-05-01 |
| Completed | Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer Breast Neoplasms | Phase 2 | 2003-01-01 |
| Completed | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lum Breast Cancer | Phase 3 | 2003-01-01 |
| Completed | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients W Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer | Phase 2 | 2001-11-01 |
| Completed | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who H Breast Cancer | Phase 3 | 2001-05-01 |
| Completed | Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Bre Breast Cancer | Phase 3 | 2001-01-01 |
| Completed | Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Posit Breast Cancer | Phase 3 | 2000-02-01 |
| Completed | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women Breast Cancer | Phase 3 | 1999-05-01 |
| Completed | Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women Wi Breast Cancer | Phase 3 | 1999-05-01 |
| Completed | Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Canc Breast Cancer | Phase 3 | 1999-03-01 |
| Completed | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer Breast Cancer | Phase 2 | 1998-06-01 |
| Completed | Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer Breast Cancer | Phase 3 | 1997-05-01 |
| Completed | Combination Chemotherapy in Treating Patients With Resected Colon Cancer Colorectal Cancer | Phase 3 | 1997-02-01 |
| Completed | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed Breast Cancer | Phase 3 | 1995-12-01 |
| Completed | Tamoxifen Study Cardiovascular Diseases, Coronary Disease, Heart Diseases | Phase 3 | 1992-05-01 |
| Completed | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Col Colorectal Cancer | Phase 3 | 1989-07-01 |
| Completed | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergo Colorectal Cancer | Phase 3 | 1984-03-01 |
| Completed | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colo Colorectal Cancer | Phase 3 | 1977-09-01 |
| Withdrawn | Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Tria Breast Cancer, Fatigue | — | — |